Skip to Main Content

Paper Details

Predicting Chemotherapy Benefit across Different Races in Early-Stage Breast Cancer Patients Using the Oncotype DX Score.
Cancers (Basel)
0
2023
ER, ER+, Early-Stage Breast Cancer, HER2, HER2-, Oncotype, Oncotype DX, Patients, breast cancer, cancer, estrogen, estrogen-receptor, patients, women
Author NameAffiliation
Christopher I AmosInstitute for Clinical and Translational Research, Baylor College of Medicine
Christopher I AmosDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
Christopher I AmosBaylor College of Medicine
Christopher I AmosInstitute for Clinical and Translational Research, Baylor College of Medicine
Christopher I AmosBaylor College of Medicine
Christopher I AmosDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
Chao ChengInstitute for Clinical and Translational Research, Baylor College of Medicine
Chao ChengBaylor College of Medicine
Chao ChengInstitute for Clinical and Translational Research, Baylor College of Medicine
Chao ChengBaylor College of Medicine
  • 1 - 10

Datasets

Release 1.2